Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thomas Gevart
Observed names:
Gevart, T.,
Gevart, Thomas
Institution:
University of Mons
Observed institutions:
Centre National de la Recherche Scientifique,
University of Mons,
École Polytechnique,
Inserm,
Laboratoire d'Optique et Biosciences,
Institut Polytechnique de Paris
show all 6
ORCID:
0009-0007-6375-2399
Observed ORCID:
0009-0007-6375-2399
OpenAlex ID:
A5015104774
Spacer engineering in nanoparticle–peptide conjugates boosts targeting specificity for tumor-associated antigens
2025
·
María de los Angeles Ramírez
, Jolie Bou-Gharios
, et al.
·
Nanoscale
·
15
PDF
High precision dual-modulation differential terahertz ATR sensor for liquid measurements
2021
·
Xiujun Zheng
, Thomas Gevart
, et al.
·
Optics Letters
·
13
Design of Iron Oxide Nanoparticles as Theranostic Nanoplatforms for Cancer Treatment
2024
·
Thomas Gevart
, Barbara Freis
, et al.
·
Topics in applied physics
·
3
PDF
In vitro and in vivo validation studies of optimized iron oxide nanoparticles carrying targeting ligands for a new therapeutic strategy in head and neck cancers
2025
·
Sonia Furgiuele
, Thomas Gevart
, et al.
·
Nanoscale Advances
·
2
PDF
MRI and optical image-guided drug delivery by pH-sensitive polymer nanocarriers
2022
·
Devreux, Marie
, Gevart, Thomas
, et al.
·
ORBi UMONS
·
1
In vitro and in vivo study of dendronized iron oxide nanoparticles designed for theranostic, in EGFR-overexpressing breast cancer context
2024
·
Gevart, Thomas
, Boutry, Sébastien
, et al.
·
ORBi UMONS
PDF
Studies of dendronized nanoparticles designed for targeted image-guided therapy in breast cancer context
2023
·
Gevart, Thomas
, C. Michel,
, et al.
·
ORBi UMONS
In vitro and in vivo Studies of dendronized nanoparticles designed for targeted theragnostic device in breast cancer context
2023
·
Gevart, Thomas
, C. Michel,
, et al.
·
ORBi UMONS
In vitro and in vivo study of dendronized iron oxide nanoparticles designed for targeted image-guided therapy in breast cancer context.
2023
·
Gevart, Thomas
, C. Michel,
, et al.
·
ORBi UMONS
Design of Iron Oxide Nanoparticles for imaging and active targeting: theranostic in one formulation
2023
·
M.D.L.A. Ramirez,
, Freis, Barbara
, et al.
·
ORBi UMONS
Breast cancer in preclinical experiments: MDA-MB-231 and 4T1 cell lines
2023
·
Gevart, Thomas
, S. Boutry,
, et al.
·
ORBi UMONS
In vitro and in vivo study of iron oxide nanoparticles designed for theranostic targeting EGFR-overexpressing tumors
2023
·
Gevart, Thomas
, Boutry, Sébastien
, et al.
·
ORBi UMONS
PDF
Theraget : In vitro and in vivo study of dendronized nanoparticles designed for theranostics in breast cancer context
2022
·
Gevart, Thomas
, Michel, C
, et al.
·
ORBi UMONS
Study of dendronized nanoparticles designed for theragnostic in breast and ovarian cancer context
2022
·
Gevart, Thomas
, Michel, C
, et al.
·
ORBi UMONS
In vitro Study of Dendronized Nanoparticles Designed for Targeted Multimodal Image Guided Therapy
2021
·
Gevart, Thomas
, Michel, C
, et al.
·
ORBi UMONS
PDF
Dendronized nanoparticles designed for targeted multimodal image guided therapy
2021
·
Laurent, Sophie
, Boutry, Sébastien
, et al.
·
ORBi UMONS
Dendronized nanoparticles designed for targeted multimodal image guided therapy
2021
·
Gevart, T.
, Laurent, Sophie
·
ORBi UMONS
Show more works
View as search
Works count:
17
Citation count:
34
H-index:
3
I10-index:
2
Year
Topic
Type